KIMS NSE filing

KIMS enters 5-year Operations & Management Agreement with Sarvottam Health Care

The RealCase readMedium impact Positive

KIMS has signed a 5-year Operations and Management Agreement with Sarvottam Health Care Private Limited. KIMS will manage the hospital and receive 9% of its net revenue. This move expands KIMS' presence in Andhra Pradesh.

Why it matters

The agreement is expected to enhance KIMS' presence in a growth region and contribute to revenue, indicating a medium-term positive impact.

The market read

The agreement is positive as it expands the company's operational reach and revenue streams.

Krishna Institute of Medical Sciences Limited (KIMS) has entered into an Operations and Management Agreement (O & M agreement) with Sarvottam Health Care Private Limited (SHPL) in Kakinada, Andhra Pradesh. This agreement is for an initial term of 5 years, with an option for a further 5-year extension, on an exclusive basis. KIMS will be responsible for running, managing, operating, directing, and controlling SHPL's hospital operations in accordance with the terms specified in the O & M agreement.

Under the terms of the agreement, KIMS is entitled to receive a revenue fee equivalent to 9% of the total Net Revenue generated by the hospital. Net Revenue is defined as gross revenue billed to patients minus any concessions and discounts offered. The hospital, operating under the brand name “Trust Multi Speciality Hospital”, currently has an installed capacity of 183 beds and commenced operations in 2010. The agreement is effective from September 10, 2026.

This O & M agreement is expected to enhance KIMS' presence in Andhra Pradesh, a region identified with significant growth potential, while SHPL will benefit from KIMS' expertise in management, operational efficiency, and medical care.

Filing to action

What to do with a filing like this

Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under strategic partnerships. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.

View original filing